EML4-ALK Rearrangement Creates a Distinctive Myeloid Cell-Dominant Immunosuppressive Microenvironment in Lung Cancer

An IL6R inhibitor transformed the tumor microenvironment in a murine anaplastic lymphoma kinase (ALK)⁺ lung adenocarcinoma model, shifting it from an immunosuppressive to a T cell–dominant status.